Antiviral Agents

"Antiviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.

Descriptor ID	D000998
MeSH Number(s)	D27.505.954.122.388
Concept/Terms	Antiviral Agents Antiviral Agents Agents, Antiviral Antivirals Antiviral Drugs Drugs, Antiviral

Below are MeSH descriptors whose meaning is more general than "Antiviral Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Anti-Infective Agents [D27.505.954.122]
Antiviral Agents [D27.505.954.122.388]

Below are MeSH descriptors whose meaning is related to "Antiviral Agents".

Below are MeSH descriptors whose meaning is more specific than "Antiviral Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Antiviral Agents" by people in this website by year, and whether "Antiviral Agents" was a major or minor topic of these publications.

Bar chart showing 208 publications over 26 distinct years, with a maximum of 17 publications in 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	1	0	1
1999	1	0	1
2000	1	0	1
2002	1	2	3
2003	5	3	8
2004	9	2	11
2005	4	1	5
2006	8	4	12
2007	7	1	8
2008	6	1	7
2009	8	2	10
2010	7	3	10
2011	8	6	14
2012	5	3	8
2013	13	1	14
2014	4	3	7
2015	5	2	7
2016	4	5	9
2017	4	1	5
2018	2	3	5
2019	3	7	10
2020	8	8	16
2021	5	6	11
2022	4	13	17
2023	0	7	7

Below are the most recent publications written about "Antiviral Agents" by people in Profiles.

Dar AA, Kim DD, Gordon SM, Klinzing K, Rosen S, Guha I, Porter N, Ortega Y, Forsyth KS, Roof J, Fazelinia H, Spruce LA, Eisenlohr LC, Behrens EM, Oliver PM. c-Myc uses Cul4b to preserve genome integrity and promote antiviral CD8+ T cell immunity. Nat Commun. 2023 Nov 04; 14(1):7098.

View in: PubMed
Gripp EW, Hess BD, Binder AF. Utility of Respiratory Pathogen Panels in the Outpatient Oncology Setting. Am J Med Qual. 2023 Nov 01; 38(6):294-299.

View in: PubMed
Bikdeli B, Khairani CD, Krishnathasan D, Bejjani A, Armero A, Tristani A, Davies J, Porio N, Assi AA, Nauffal V, Campia U, Almarzooq Z, Wei E, Achanta A, Jesudasen SJ, Tiu BC, Merli GJ, Leiva O, Fanikos J, Sharma A, Vishnevsky A, Hsia J, Nehler MR, Welker J, Bonaca MP, Carroll BJ, Lan Z, Goldhaber SZ, Piazza G. Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study. Thromb Res. 2023 Aug; 228:94-104.

View in: PubMed
Pal S, Garg A, Agarwal A, Ghoshal U, Singh P, Chahar JS, Gurjar M. Cytomegalovirus reactivation with high viral load in a patient of coronavirus disease 2019 acute respiratory distress syndrome: a case report. J Med Case Rep. 2023 May 16; 17(1):215.

View in: PubMed
Di Martino A, Stefanini N, Brunello M, Bordini B, Pilla F, Geraci G, D'Agostino C, Ruta F, Faldini C. Is the Direct Anterior Approach for Total Hip Arthroplasty Effective in Obese Patients? Early Clinical and Radiographic Results from a Retrospective Comparative Study. Medicina (Kaunas). 2023 Apr 16; 59(4).

View in: PubMed
Moradi H, Bunnell HT, Price BS, Khodaverdi M, Vest MT, Porterfield JZ, Anzalone AJ, Santangelo SL, Kimble W, Harper J, Hillegass WB, Hodder SL. Assessing the effects of therapeutic combinations on SARS-CoV-2 infected patient outcomes: A big data approach. PLoS One. 2023; 18(3):e0282587.

View in: PubMed
Beyoglu D, Schwalm S, Semmo N, Huwiler A, Idle JR. Hepatitis C Virus Infection Upregulates Plasma Phosphosphingolipids and Endocannabinoids and Downregulates Lysophosphoinositols. Int J Mol Sci. 2023 01 11; 24(2).

View in: PubMed
Burdette D, Hyrina A, Song Z, Beran RK, Cheung T, Gilmore S, Kobayashi T, Li L, Liu Y, Niedziela-Majka A, Medley J, Mehra U, Morganelli P, Novikov N, Niu C, Tam D, Tang J, Wang J, Yue Q, Fletcher SP, Holdorf MM, Delaney WE, Feierbach B, Lazerwith S. Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus Infection. Antimicrob Agents Chemother. 2023 01 24; 67(1):e0134822.

View in: PubMed
Yost CC, Jimenez DC, Weber MP, Maynes EJ, Belden KA, Tchantchaleishvili V, Massey HT, Sass DA, Rame JE, Zurlo JJ, Aburjania N. Hepatitis B in Heart Transplant Donors and Recipients: A Systematic Review and Meta-Analysis. J Surg Res. 2023 03; 283:1078-1090.

View in: PubMed
Gilmore SA, Tam D, Cheung TL, Snyder C, Farand J, Dick R, Matles M, Feng JY, Ramirez R, Li L, Yu H, Xu Y, Barnes D, Czerwieniec G, Brendza KM, Appleby TC, Birkus G, Willkom M, Kobayashi T, Paoli E, Labelle M, Boesen T, Tay CH, Delaney WE, Notte GT, Schmitz U, Feierbach B. Characterization of a KDM5 small molecule inhibitor with antiviral activity against hepatitis B virus. PLoS One. 2022; 17(12):e0271145.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement